![](https://pharmasource.global/wp-content/uploads/2023/01/Pharma_Manfacturing-1-300x199.jpg)
Community
Why M&A can be the most Cost-Effective Strategy for Pharma Manufacturing
Rushabh Shah Deputy General Manager of Amneal Pharmaceuticals examines the benefits of using M&A as a procurement strategy for pharmaceutical companies.
Rushabh Shah Deputy General Manager of Amneal Pharmaceuticals examines the benefits of using M&A as a procurement strategy for pharmaceutical companies.
Fuliginous Management Consulting regularly tracks the outsourcing activity of 320 pharma companies operating in Europe. In this new research, Kyriakos Kansos reveals some of the key trends in external manufacturing and advises how companies can optimise their pharmaceutical manufacturing network.
Help us find the most innovative and trusted suppliers in Pharma and Biotech.